% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Verger:1041313,
      author       = {Verger, Antoine and Tolboom, Nelleke and Cicone, Francesco
                      and Chang, Susan M. and Furtner, Julia and Galldiks, Norbert
                      and Gempt, Jens and Guedj, Eric and Huang, Raymond Y. and
                      Johnson, Derek R. and Law, Ian and Le Rhun, Emilie and
                      Short, Susan C. and Bent, M. J. Van den and Weehaeghe,
                      Donatienne Van and Vogelbaum, Michael A. and Wen, Patrick Y.
                      and Albert, Nathalie L. and Preusser, Matthias},
      title        = {{J}oint {EANM}/{EANO}/{RANO}/{SNMMI} practice
                      guideline/procedure standard for {PET} imaging of brain
                      metastases: version 1.0},
      journal      = {European journal of nuclear medicine and molecular imaging},
      volume       = {52},
      number       = {5},
      issn         = {1619-7070},
      address      = {Heidelberg [u.a.]},
      publisher    = {Springer-Verl.},
      reportid     = {FZJ-2025-02212},
      pages        = {1822 - 1839},
      year         = {2025},
      abstract     = {This joint practice guideline/procedure standard was
                      collaboratively developed by the European Association of
                      Nuclear Medicine (EANM), the Society of Nuclear Medicine and
                      Molecular Imaging (SNMMI), the European Association of
                      Neuro-Oncology (EANO), and the PET task force of the
                      Response Assessment in Neurooncology Working Group
                      (PET/RANO). Brain metastases are the most common malignant
                      central nervous system (CNS) tumors. PET imaging with
                      radiolabeled amino acids and to lesser extent [18F]FDG has
                      gained considerable importance in the assessment of brain
                      metastases, especially for the differential diagnosis
                      between recurrent metastases and treatment-related changes
                      which remains a limitation using conventional MRI. The aim
                      of this guideline is to assist nuclear medicine physicians
                      in recommending, performing, interpreting and reporting the
                      results of brain PET imaging in patients with brain
                      metastases. This practice guideline will define procedure
                      standards for the application of PET imaging in patients
                      with brain metastases in routine practice and clinical
                      trials and will help to harmonize data acquisition and
                      interpretation across centers.Keywords: Brain metastases;
                      Brain metastasis; FDG; FDOPA; FET; Fluciclovine; Metastatic
                      brain tumors; Methionine; PET; Recurrence.},
      cin          = {INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-3-20090406},
      pnm          = {5252 - Brain Dysfunction and Plasticity (POF4-525)},
      pid          = {G:(DE-HGF)POF4-5252},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {39762634},
      UT           = {WOS:001390889200001},
      doi          = {10.1007/s00259-024-07038-5},
      url          = {https://juser.fz-juelich.de/record/1041313},
}